XRP Healthcare is moving steadily toward a proposed public listing on the TSX Venture Exchange (TSXV), marking a major step in its mission to transform private healthcare across Africa through M&A, AI, and strategic licensing. While the listing is not yet complete and remains subject to regulatory approval, key milestones have been achieved – including a signed LOI and Definitive Agreement with AAJ Capital 3 Corp., corporate restructuring, legal readiness, and financial audits.This strategic path to public markets reinforces the company’s long-term vision: to bridge systemic gaps in healthcare access and delivery by combining real-world consolidation with scalable technology. The TSXV, known for supporting early-stage, high-growth companies, offers XRP Healthcare a regulatory environment that values transparency, structure, and scalability – aligning well with the company’s operational roadmap.Strengthening Foundations Through M&AAs part of its M&A rollout, the company has completed seven key pharmacy acquisitions across Uganda under its anchor asset, Pharma Ville – comprising five wholesale and two retail outlets. These acquisitions provide a tangible foundation in a critical gateway market, where demand for accessible and reliable healthcare solutions continues to rise. The company views Uganda not only as an operational launchpad but as a proving ground for its expansion model across Sub-Saharan Africa.These facilities are being integrated into a broader consolidation strategy focused on streamlining operations, improving pharmaceutical distribution, and leveraging data across its pharmacy network. The company continues to evaluate additional acquisition targets with the goal of scaling sustainably while maintaining clinical and regulatory standards.XRPH AI: A Scalable Digital Health CompanionComplementing its physical strategy is the XRPH AI App, a multilingual, consumer-facing platform designed to address healthcare fragmentation through digital access. Built with accessibility and local relevance in mind, the app is structured to serve both urban and rural populations who often face barriers to care.Key features include:• Doctor Connect – now live, enabling users to directly engage with licensed medical professionals for accessible health guidance.• AI Health Support – providing symptom assistance and health education, backed by trusted sources and designed to support early intervention.• Prescription Scanner – allowing users to upload prescriptions and receive interpretations to promote medication clarity and safety.• XRPH Prescription Savings Card – offering discounts at over 68,000 pharmacies across the U.S., including major chains like Walmart, CVS, and Walgreens.This blend of technology and localized functionality positions XRPH AI as an essential tool in overcoming both physical and informational barriers to care – particularly in regions where healthcare infrastructure is still developing.Licensing as a Force MultiplierIn parallel with its M&A and technology initiatives, XRP Healthcare is introducing a licensing model to rapidly expand its footprint with low overhead. This strategy allows qualified operators to use the company’s brand, technology stack, and operational standards to deliver healthcare under a unified framework – without the need for XRP Healthcare to own and manage each location.The model offers several advantages:• Scalability: Enables faster expansion into multiple markets simultaneously• Cost Efficiency: Reduces capital expenditure while maximizing brand reach• Local Empowerment: Leverages in-country expertise and infrastructure• Quality Control: Maintains consistency through standard operating procedures and technology oversightLicensing, when paired with AI and a strong acquisition base, creates a unique triangle of growth that few healthcare startups in emerging markets can offer – allowing the company to scale vertically and horizontally with minimal friction.On Track for Public Market EntryWith the proposed TSXV listing targeted for this quarter, XRP Healthcare continues to execute with regulatory discipline and long-term impact in mind. The public listing is expected to strengthen investor confidence, enhance capital access, and elevate the company’s global visibility as it seeks to play a defining role in Africa’s $259 billion healthcare opportunity by 2030.As regulatory filings progress and institutional interest grows, XRP Healthcare remains focused on building an ecosystem that blends innovation with infrastructure, digital reach with real-world presence, and purpose with performance.Forward-Looking Statement DisclaimerThis communication may contain “forward-looking statements” within the meaning of applicable securities laws. Forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties, and other factors which may cause actual results or developments to differ materially from those expressed or implied herein.Readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. XRP Healthcare undertakes no obligation to update or revise any forward-looking statements, except as required by law.
XRP Healthcare is moving steadily toward a proposed public listing on the TSX Venture Exchange (TSXV), marking a major step in its mission to transform private healthcare across Africa through M&A, AI, and strategic licensing. While the listing is not yet complete and remains subject to regulatory approval, key milestones have been achieved – including a signed LOI and Definitive Agreement with AAJ Capital 3 Corp., corporate restructuring, legal readiness, and financial audits.
This strategic path to public markets reinforces the company’s long-term vision: to bridge systemic gaps in healthcare access and delivery by combining real-world consolidation with scalable technology. The TSXV, known for supporting early-stage, high-growth companies, offers XRP Healthcare a regulatory environment that values transparency, structure, and scalability – aligning well with the company’s operational roadmap.
Strengthening Foundations Through M&A
As part of its M&A rollout, the company has completed seven key pharmacy acquisitions across Uganda under its anchor asset, Pharma Ville – comprising five wholesale and two retail outlets. These acquisitions provide a tangible foundation in a critical gateway market, where demand for accessible and reliable healthcare solutions continues to rise. The company views Uganda not only as an operational launchpad but as a proving ground for its expansion model across Sub-Saharan Africa.
These facilities are being integrated into a broader consolidation strategy focused on streamlining operations, improving pharmaceutical distribution, and leveraging data across its pharmacy network. The company continues to evaluate additional acquisition targets with the goal of scaling sustainably while maintaining clinical and regulatory standards.
XRPH AI: A Scalable Digital Health Companion
Complementing its physical strategy is the XRPH AI App, a multilingual, consumer-facing platform designed to address healthcare fragmentation through digital access. Built with accessibility and local relevance in mind, the app is structured to serve both urban and rural populations who often face barriers to care.
Key features include:
• Doctor Connect – now live, enabling users to directly engage with licensed medical professionals for accessible health guidance.
• AI Health Support – providing symptom assistance and health education, backed by trusted sources and designed to support early intervention.
• Prescription Scanner – allowing users to upload prescriptions and receive interpretations to promote medication clarity and safety.
• XRPH Prescription Savings Card – offering discounts at over 68,000 pharmacies across the U.S., including major chains like Walmart, CVS, and Walgreens.
This blend of technology and localized functionality positions XRPH AI as an essential tool in overcoming both physical and informational barriers to care – particularly in regions where healthcare infrastructure is still developing.
Licensing as a Force Multiplier
In parallel with its M&A and technology initiatives, XRP Healthcare is introducing a licensing model to rapidly expand its footprint with low overhead. This strategy allows qualified operators to use the company’s brand, technology stack, and operational standards to deliver healthcare under a unified framework – without the need for XRP Healthcare to own and manage each location.
The model offers several advantages:
• Scalability: Enables faster expansion into multiple markets simultaneously
• Cost Efficiency: Reduces capital expenditure while maximizing brand reach
• Local Empowerment: Leverages in-country expertise and infrastructure
• Quality Control: Maintains consistency through standard operating procedures and technology oversight
Licensing, when paired with AI and a strong acquisition base, creates a unique triangle of growth that few healthcare startups in emerging markets can offer – allowing the company to scale vertically and horizontally with minimal friction.
On Track for Public Market Entry
With the proposed TSXV listing targeted for this quarter, XRP Healthcare continues to execute with regulatory discipline and long-term impact in mind. The public listing is expected to strengthen investor confidence, enhance capital access, and elevate the company’s global visibility as it seeks to play a defining role in Africa’s $259 billion healthcare opportunity by 2030.
As regulatory filings progress and institutional interest grows, XRP Healthcare remains focused on building an ecosystem that blends innovation with infrastructure, digital reach with real-world presence, and purpose with performance.
Forward-Looking Statement Disclaimer
This communication may contain “forward-looking statements” within the meaning of applicable securities laws. Forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties, and other factors which may cause actual results or developments to differ materially from those expressed or implied herein.
Readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. XRP Healthcare undertakes no obligation to update or revise any forward-looking statements, except as required by law.
